Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaiqing Li

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|October 24, 2024
Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney diseaseKaiqing Li, Xue Xia, Ying Tong
Frontiers in Behavioral Neuroscience|August 29, 2025
The central role of microglia in major depressive disorder and its potential as a therapeutic targetXue Xia, Kaiqing Li, Wei Zou, et al.
Pharmacological Research|August 4, 2024
Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis"Kaiqing Li, Xue Xia, Tong Fu, et al.
Pharmacological Research|August 17, 2024
Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis"Kaiqing Li, Xue Xia, Tong Fu, et al.
International Journal of General Medicine|November 13, 2025
Comprehensive Treatment of Gout with Traditional Chinese Medicine: A Modern Pathophysiological PerspectiveJiamin Yang, Rui Xu, Kaiqing Li, et al.
Asian Journal of Psychiatry|September 11, 2025
Mitochondrial dysfunction in depression: Mechanisms and targeted therapy strategiesXue Xia, Kaiqing Li, Baiyi Jiang, et al.
Antibiotics (Basel, Switzerland)|October 23, 2021
RIP3 Associates with RIP1, TRIF, MAVS, and Also IRF3/7 in Host Innate Immune Signaling in Large Yellow Croaker <i>Larimichthys crocea</i>Pengfei Zou, Kaiqing Li, Ying Li, et al.
Frontiers in Immunology|October 23, 2024
Clinical advances and challenges associated with TCR-T cell therapy for cancer treatmentJianing Li, Yongsheng Zhang, Tong Fu, et al.
Frontiers in Pharmacology|September 8, 2025
Progress in animal models for studying hyperuricemiaSenyue Zhang, Kaiqing Li, Hu Zhang, et al.
Medicine|July 28, 2023
Treatment of Parkinson disease by acupuncture combined with medicine based on syndrome differentiation from the perspective of modern medicine: A reviewXue Xia, Xu Dong, Kaiqing Li, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|October 24, 2024
Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney diseaseKaiqing Li, Xue Xia, Ying Tong
Frontiers in Behavioral Neuroscience|August 29, 2025
The central role of microglia in major depressive disorder and its potential as a therapeutic targetXue Xia, Kaiqing Li, Wei Zou, et al.
Pharmacological Research|August 4, 2024
Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis"Kaiqing Li, Xue Xia, Tong Fu, et al.
Pharmacological Research|August 17, 2024
Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis"Kaiqing Li, Xue Xia, Tong Fu, et al.
International Journal of General Medicine|November 13, 2025
Comprehensive Treatment of Gout with Traditional Chinese Medicine: A Modern Pathophysiological PerspectiveJiamin Yang, Rui Xu, Kaiqing Li, et al.
Asian Journal of Psychiatry|September 11, 2025
Mitochondrial dysfunction in depression: Mechanisms and targeted therapy strategiesXue Xia, Kaiqing Li, Baiyi Jiang, et al.
Antibiotics (Basel, Switzerland)|October 23, 2021
RIP3 Associates with RIP1, TRIF, MAVS, and Also IRF3/7 in Host Innate Immune Signaling in Large Yellow Croaker <i>Larimichthys crocea</i>Pengfei Zou, Kaiqing Li, Ying Li, et al.
Frontiers in Immunology|October 23, 2024
Clinical advances and challenges associated with TCR-T cell therapy for cancer treatmentJianing Li, Yongsheng Zhang, Tong Fu, et al.
Frontiers in Pharmacology|September 8, 2025
Progress in animal models for studying hyperuricemiaSenyue Zhang, Kaiqing Li, Hu Zhang, et al.
Medicine|July 28, 2023
Treatment of Parkinson disease by acupuncture combined with medicine based on syndrome differentiation from the perspective of modern medicine: A reviewXue Xia, Xu Dong, Kaiqing Li, et al.
Pageof 2